Stock Evaluator: MediWound Ltd. (MDWD)

MediWound Ltd. MDWD

$13.59 0.05 0.37%
November 20, 2026 3:59:55 PM EST November 10, 2021 Volume: 187,835
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Pharmaceuticals

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

Commentary & Analysis


Financial Summary

Share Statistics MDWD Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $194.6 $421.5 29%
Shares Out (Mil) 13.2 46.9 24%
Institutional Ownership 93.8% 82.0% 63%
Float (Mil) 9.8 49.2 19%
Beta 0.04 0.68 6%
Avg Daily Volume (000s) 201 347 44%
Price Change
(52-week)
(23.7%) 49.3% 36%
Growth MDWD Industry
Median
Percentile
(All Stocks)
Sales (5yr) (4.9%) 6.4% 9%
Net Income (5yr) (21.0%) (1.3%) 19%
EPS (5yr) 2.4% 15.1% 35
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (16.5%) (15.0%) 43%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 6 6 6
Current EPS ($0.615) ($2.017) ($2.160)
Month Ago EPS ($0.656) ($2.230) ($2.290)
# Rev Up 0 1 1
# Rev Down 1 0 1
Three Months Ago EPS ($0.656) ($2.230) ($2.290)
Year/Year Chg (20.1%) (3.9%) (28.2%)
Financials MDWD Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $12 $275 9%
Net Income (TTM) (Mil) ($20) ($11) 23%
EPS (TTM) ($1.627) ($0.700) 16%
Operating Cash Flow (TTM) (Mil) ($22) ($7) 14%
Net Cash Flow (TTM) (Mil) ($37) $1 23%
Long-Term Debt (Q1) (Mil) $9 $6 27%
Enterprise Value (Q1) (Mil) $162 $331 26%
Valuation MDWD Industry
Median
Percentile
(All Stocks)
P/B 4.93 2.08 82%
P/E na 20.9 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios MDWD Industry
Median
Percentile
(All Stocks)
Gross Margin 19.5% 69.5% 20%
Net Margin (235.0%) 3.6% 4%
ROA (31.2%) (23.8%) 16%
ROE (75.4%) (24.2%) 11%
Liabilities to Assets 50.4% 31.6% 43%
F-Score 3 3 18%

MediWound Ltd. did not pass any screens on 11/20/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors